300463 迈克生物
已收盘 06-30 15:00:00
资讯
新帖
简况
股市必读:迈克生物(300463)6月24日董秘有最新回复
证券之星 · 06-25
股市必读:迈克生物(300463)6月24日董秘有最新回复
迈克生物:构建“检验数据工厂+智能决策中心”两大核心价值单元
证券之星 · 06-24
迈克生物:构建“检验数据工厂+智能决策中心”两大核心价值单元
迈克生物:公司2026年将重点围绕智慧化实验室解决方案
证券之星 · 06-24
迈克生物:公司2026年将重点围绕智慧化实验室解决方案
迈克生物:经销收入占比已达76.1%
证券之星 · 06-24
迈克生物:经销收入占比已达76.1%
迈克生物:计划回购股份用于注销并减少注册资本
证券之星 · 06-23
迈克生物:计划回购股份用于注销并减少注册资本
迈克生物:公司目前贷款、质押、担保业务均正常开展
证券之星 · 06-23
迈克生物:公司目前贷款、质押、担保业务均正常开展
迈克生物:未发现大股东存在违反破发破净情形下违规减持的行为
证券之星 · 06-23
迈克生物:未发现大股东存在违反破发破净情形下违规减持的行为
迈克生物(300463)披露回购股份事项前十名股东持股情况公告,6月23日股价上涨1.75%
证券之星 · 06-23
迈克生物(300463)披露回购股份事项前十名股东持股情况公告,6月23日股价上涨1.75%
迈克生物:致力于成为全球领先的体外诊断企业
证券之星 · 06-23
迈克生物:致力于成为全球领先的体外诊断企业
迈克生物:截至2026年一季度末,公司应收账款约10.53亿元
证券之星 · 06-23
迈克生物:截至2026年一季度末,公司应收账款约10.53亿元
每周股票复盘:迈克生物(300463)拟回购5000万至1亿元股份
证券之星 · 06-21
每周股票复盘:迈克生物(300463)拟回购5000万至1亿元股份
迈克生物(300463)披露回购公司股份方案的公告,6月18日股价上涨0.12%
证券之星 · 06-18
迈克生物(300463)披露回购公司股份方案的公告,6月18日股价上涨0.12%
迈克生物最新公告:拟5000万元至1亿元回购股份
证券之星 · 06-18
迈克生物最新公告:拟5000万元至1亿元回购股份
迈克生物:目前公司核心原料自给率近70%
证券之星 · 06-17
迈克生物:目前公司核心原料自给率近70%
股市必读:迈克生物(300463)6月16日董秘有最新回复
证券之星 · 06-17
股市必读:迈克生物(300463)6月16日董秘有最新回复
迈克生物:智慧化实验室强调生态完整性和业态主体独家性
证券之星 · 06-16
迈克生物:智慧化实验室强调生态完整性和业态主体独家性
迈克生物:未布局AI算力相关业务及相关产业转型
证券之星 · 06-05
迈克生物:未布局AI算力相关业务及相关产业转型
迈克生物:智慧化实验室以患者为中心
证券之星 · 06-04
迈克生物:智慧化实验室以患者为中心
迈克生物:国内构建三级经销渠道
证券之星 · 06-04
迈克生物:国内构建三级经销渠道
迈克生物:公司对该业务的中长期发展目标保持坚定信心
证券之星 · 06-02
迈克生物:公司对该业务的中长期发展目标保持坚定信心
加载更多
公司概况
公司名称:
迈克生物股份有限公司
所属行业:
医药制造业
上市日期:
2015-05-28
主营业务:
迈克生物股份有限公司的主营业务是体外诊断产品的研发、生产、销售和服务。公司的主要产品是免疫、生化、分子诊断提取、分子诊断荧光PCR、血常规产品、凝血产品、血型产品、血气产品、尿液产品。
发行价格:
27.96
{"stockData":{"symbol":"300463","market":"SZ","secType":"STK","nameCN":"迈克生物","latestPrice":8.26,"timestamp":1782803034000,"preClose":8.37,"halted":0,"volume":4762589,"delay":0,"changeRate":-0.0131,"floatShares":492000000,"shares":605000000,"eps":-0.0841,"marketStatus":"已收盘","change":-0.11,"latestTime":"06-30 15:00:00","open":8.37,"high":8.39,"low":8.19,"amount":39315900,"amplitude":0.0239,"askPrice":8.26,"askSize":59,"bidPrice":8.25,"bidSize":481,"shortable":0,"etf":0,"ttmEps":-0.0841,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1782869400000},"marketStatusCode":5,"adr":0,"adjPreClose":8.37,"symbolType":"stock","openAndCloseTimeList":[[1782783000000,1782790200000],[1782795600000,1782802800000]],"highLimit":9.21,"lowLimit":7.53,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":604666624,"isCdr":false,"pbRate":0.81,"roa":"--","roe":"0.14%","epsLYR":-0.0593,"committee":0.230578,"marketValue":4995000000,"turnoverRate":0.0097,"status":1,"floatMarketCap":4061000000},"requestUrl":"/m/hq/s/300463","defaultTab":"news","newsList":[{"id":"2646845605","title":"股市必读:迈克生物(300463)6月24日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2646845605","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646845605?lang=zh_cn&edition=full","pubTime":"2026-06-25 04:10","pubTimestamp":1782331823,"startTime":"0","endTime":"0","summary":"截至2026年6月24日收盘,迈克生物报收于8.57元,下跌1.49%,换手率1.37%,成交量6.74万手,成交额5801.33万元。董秘最新回复投资者: 董秘您好,想咨询下公司智慧实验室相关业务中 AI 技术的应用落地情况。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062500003643.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","300463","BK0028","BK0239","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645098813","title":"迈克生物:构建“检验数据工厂+智能决策中心”两大核心价值单元","url":"https://stock-news.laohu8.com/highlight/detail?id=2645098813","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645098813?lang=zh_cn&edition=full","pubTime":"2026-06-24 20:53","pubTimestamp":1782305600,"startTime":"0","endTime":"0","summary":"证券之星消息,迈克生物06月24日在投资者关系平台上答复投资者关心的问题。迈克“智汇”实验室以患者为中心,打造基于自动化、数智化的医学实验室全面解决方案,构建“检验数据工厂+智能决策中心”两大核心价值单元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062400042135.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0012","300463","BK0046","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645628868","title":"迈克生物:公司2026年将重点围绕智慧化实验室解决方案","url":"https://stock-news.laohu8.com/highlight/detail?id=2645628868","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645628868?lang=zh_cn&edition=full","pubTime":"2026-06-24 08:57","pubTimestamp":1782262630,"startTime":"0","endTime":"0","summary":"证券之星消息,迈克生物06月23日在投资者关系平台上答复投资者关心的问题。投资者提问:公司覆盖生化、发光、分子多平台,2026 年分子、血气等第二业务增速预期多少?公司2026年将重点围绕智慧化实验室解决方案,加强产品实现与迭代;加强国内市场推广落地,深化全球化布局与海外市场突破;强化经营管理,切实落实提质增效。具体增速情况请参见公司在法定信息披露媒体巨潮资讯网上发布的定期报告。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062400008275.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","BK0012","BK0046","300463"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645686928","title":"迈克生物:经销收入占比已达76.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645686928","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645686928?lang=zh_cn&edition=full","pubTime":"2026-06-24 08:52","pubTimestamp":1782262328,"startTime":"0","endTime":"0","summary":"证券之星消息,迈克生物(300463)06月23日在投资者关系平台上答复投资者关心的问题。投资者提问:公司推进直营转分销渠道改革后,应收账款周转、财务费用、现金流改善是否达到内部预期?今年对核心经销商有无加码扶持政策?迈克生物回复:尊敬的投资者,您好!近年来公司一直在主动进行直销向经销的调整,截至2025年,经销收入占比已达76.1%,调整已基本到位,经销体系趋于稳定。为更好的推动智慧化实验室的市场拓展,公司在发展经销商时会从经销商能力、覆盖范围等进行综合考量,选择更有能力和市场影响力的合作伙伴。感谢您的关注与支持!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:沈彬","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062400008209.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0239","BK0028","BK0046","300463"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645629839","title":"迈克生物:计划回购股份用于注销并减少注册资本","url":"https://stock-news.laohu8.com/highlight/detail?id=2645629839","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645629839?lang=zh_cn&edition=full","pubTime":"2026-06-23 20:51","pubTimestamp":1782219099,"startTime":"0","endTime":"0","summary":"证券之星消息,迈克生物06月22日在投资者关系平台上答复投资者关心的问题。公司基于对自身发展前景的信心和内在价值的认可,结合财务状况、经营状况和发展战略的充分考虑,计划使用自有资金以集中竞价交易方式回购部分公司已发行的人民币普通股(A股)股票,用于注销并减少注册资本。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062300040161.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0239","300463","BK0012","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645839642","title":"迈克生物:公司目前贷款、质押、担保业务均正常开展","url":"https://stock-news.laohu8.com/highlight/detail?id=2645839642","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645839642?lang=zh_cn&edition=full","pubTime":"2026-06-23 20:51","pubTimestamp":1782219098,"startTime":"0","endTime":"0","summary":"证券之星消息,迈克生物06月22日在投资者关系平台上答复投资者关心的问题。公司目前贷款、质押、担保业务均正常开展,未受到市值波动的明显影响。公司认为市值管理的核心在于持续提升内在价值,公司将继续专注主业、稳健经营,努力以良好的经营业绩推动公司价值与市值长期健康发展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062300040159.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0239","BK0046","300463","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645839671","title":"迈克生物:未发现大股东存在违反破发破净情形下违规减持的行为","url":"https://stock-news.laohu8.com/highlight/detail?id=2645839671","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645839671?lang=zh_cn&edition=full","pubTime":"2026-06-23 20:51","pubTimestamp":1782219087,"startTime":"0","endTime":"0","summary":"证券之星消息,迈克生物(300463)06月22日在投资者关系平台上答复投资者关心的问题。投资者提问:公司目前股价破净资产,根据减持新规,大股东在破发破净时不得减持,公司请自查是否有大股东违规减持行为迈克生物回复:答:尊敬的投资者,您好!根据《上市公司股东减持股份管理暂行办法》等相关规定,公司已对相关人员进行自查,截至目前,未发现大股东存在违反破发破净情形下违规减持的行为。公司将持续督促股东严格遵守减持规定,并及时履行信息披露义务。感谢您的关注与支持!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062300040149.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0046","300463","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645871308","title":"迈克生物(300463)披露回购股份事项前十名股东持股情况公告,6月23日股价上涨1.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645871308","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645871308?lang=zh_cn&edition=full","pubTime":"2026-06-23 17:53","pubTimestamp":1782208418,"startTime":"0","endTime":"0","summary":"截至2026年6月23日收盘,迈克生物报收于8.7元,较前一交易日上涨1.75%,最新总市值为52.61亿元。该股当日开盘8.52元,最高8.91元,最低8.51元,成交额达9468.04万元,换手率为2.2%。近日,迈克生物发布《关于回购股份事项前十名股东及前十名无限售条件股东持股情况的公告》。公告同步披露了董事会公告回购决议前一交易日登记在册的前十名股东及前十名无限售条件股东的持股情况,相关数据来源于中国证券登记结算有限责任公司深圳分公司出具的股东名册。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062300031327.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0012","300463","BK0046","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645006260","title":"迈克生物:致力于成为全球领先的体外诊断企业","url":"https://stock-news.laohu8.com/highlight/detail?id=2645006260","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645006260?lang=zh_cn&edition=full","pubTime":"2026-06-23 08:30","pubTimestamp":1782174625,"startTime":"0","endTime":"0","summary":"证券之星消息,迈克生物(300463)06月22日在投资者关系平台上答复投资者关心的问题。投资者提问:公司布局智慧大医疗如何一步步成为世界巨头迈克生物回复:尊敬的投资者,您好!公司致力于成为全球领先的体外诊断企业,一是持续研发创新;二是深化智慧化实验室解决方案,加强产品实现与迭代;三是推进海外战略聚焦“12+1”重点区域,深化全球化布局与海外市场突破;四是积极应对集采政策,提升自主产品竞争力。公司将继续专注主业、稳健经营,持续为股东创造长期价值。感谢您的关注与支持!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:陈思雨","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062300007206.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0239","BK0046","300463","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645061080","title":"迈克生物:截至2026年一季度末,公司应收账款约10.53亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2645061080","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645061080?lang=zh_cn&edition=full","pubTime":"2026-06-23 08:27","pubTimestamp":1782174425,"startTime":"0","endTime":"0","summary":"证券之星消息,迈克生物06月22日在投资者关系平台上答复投资者关心的问题。截至最近报告期,公司应收账款高达13.2亿元,占净利润比例超1000%,其中超65%账龄在一年以内。考虑到当前医保控费、集采降价的行业环境,且公司2025年已出现亏损,请问:公司针对存量应收账款的具体催收计划是什么?能否披露2026年上半年应收账款回款率目标?截至2026年一季度末,公司应收账款约10.53亿元,较2025年末下降7.47%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062300007122.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0046","BK0028","BK0239","300463"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645969860","title":"每周股票复盘:迈克生物(300463)拟回购5000万至1亿元股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2645969860","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645969860?lang=zh_cn&edition=full","pubTime":"2026-06-21 03:04","pubTimestamp":1781982252,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘,迈克生物报收于8.39元,较上周的8.54元下跌1.76%。本周,迈克生物6月15日盘中最高价报8.7元。本周关注点公司公告汇总:迈克生物拟使用自有资金回购股份,金额不低于5,000万元且不超过10,000万元。本次回购股份用于注销并减少注册资本。预计回购股份数量为3,410,641股至6,821,282股,占公司当前总股本的0.56%至1.13%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062100000953.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","300463","BK0012","BK0239","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644084473","title":"迈克生物(300463)披露回购公司股份方案的公告,6月18日股价上涨0.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2644084473","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644084473?lang=zh_cn&edition=full","pubTime":"2026-06-18 22:45","pubTimestamp":1781793918,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘,迈克生物报收于8.39元,较前一交易日上涨0.12%,最新总市值为50.73亿元。该股当日开盘8.38元,最高8.53元,最低8.29元,成交额达5558.55万元,换手率为1.34%。近日,迈克生物股份有限公司披露《关于回购公司股份方案的公告》。本次回购股份用于注销并减少注册资本。预计回购股份数量为3,410,641股至6,821,282股,占公司当前总股本的0.56%至1.13%。回购实施期限为自股东会审议通过之日起12个月内。本次回购不会损害公司债务履行能力和持续经营能力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061800042915.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0046","BK0012","300463","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644046737","title":"迈克生物最新公告:拟5000万元至1亿元回购股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2644046737","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644046737?lang=zh_cn&edition=full","pubTime":"2026-06-18 17:51","pubTimestamp":1781776279,"startTime":"0","endTime":"0","summary":"迈克生物(300463.SZ)公告称,公司拟使用自有资金以集中竞价方式回购股份,资金总额不低于5000万元且不超过1亿元,回购价格不超过14.66元/股。回购股份将全部用于注销并减少注册资本,实施期限为股东会审议通过之日起12个月内。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061800031915.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300463","BK0028","BK0239","BK0012","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644799422","title":"迈克生物:目前公司核心原料自给率近70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2644799422","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644799422?lang=zh_cn&edition=full","pubTime":"2026-06-17 08:48","pubTimestamp":1781657290,"startTime":"0","endTime":"0","summary":"证券之星消息,迈克生物06月16日在投资者关系平台上答复投资者关心的问题。核心原料是决定诊断产品性能、质量与成本的核心关键。目前公司核心原料自给率近70%,规模化自主生产有效降低原材料采购成本,持续优化盈利结构。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061700007382.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","300463","BK0239","BK0012","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644625917","title":"股市必读:迈克生物(300463)6月16日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2644625917","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644625917?lang=zh_cn&edition=full","pubTime":"2026-06-17 02:54","pubTimestamp":1781636050,"startTime":"0","endTime":"0","summary":"截至2026年6月16日收盘,迈克生物报收于8.47元,下跌2.08%,换手率1.4%,成交量6.86万手,成交额5815.64万元。董秘最新回复投资者: 董秘您好,公司智慧化实验室产品能显著帮助ICL压缩运营成本,对民营第三方实验室性价比突出。公司针对智慧化实验室业务已组建专属专项团队,全链条统筹推进市场拓展与落地交付。当日关注点交易信息汇总:6月16日主力资金净流出661.01万元,游资资金净流入285.2万元,散户资金净流入375.81万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061700001126.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0028","300463","BK0239","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643732810","title":"迈克生物:智慧化实验室强调生态完整性和业态主体独家性","url":"https://stock-news.laohu8.com/highlight/detail?id=2643732810","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643732810?lang=zh_cn&edition=full","pubTime":"2026-06-16 15:45","pubTimestamp":1781595910,"startTime":"0","endTime":"0","summary":"证券之星消息,迈克生物06月16日在投资者关系平台上答复投资者关心的问题。公司将在后续的沟通中,加强对智慧化实验室的宣传。智慧化实验室与流水线的逻辑差异较大,智慧化实验室强调生态完整性和业态主体独家性,通过全自动、全流程实现无人化操作,进行检测流程再造和工业化水平提升。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061600023390.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","BK0046","BK0012","300463"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641148230","title":"迈克生物:未布局AI算力相关业务及相关产业转型","url":"https://stock-news.laohu8.com/highlight/detail?id=2641148230","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641148230?lang=zh_cn&edition=full","pubTime":"2026-06-05 20:48","pubTimestamp":1780663699,"startTime":"0","endTime":"0","summary":"证券之星消息,迈克生物06月04日在投资者关系平台上答复投资者关心的问题。结合当前 AI 算力行业高景气行情,公司现有资金储备充足,且已有实验室 AI 技术落地应用,想咨询两点:1、公司主业体外诊断短期承压、业绩阶段性下滑,管理层是否研讨过跨界布局 AI 算力相关业务、进行产业转型?公司 未布局AI 算力相关业务及相关产业转型,公司的指定信息披露网站为巨潮资讯网,请以官方途径获取的信息为准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060500038650.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","300463","BK0012","BK0239","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640013336","title":"迈克生物:智慧化实验室以患者为中心","url":"https://stock-news.laohu8.com/highlight/detail?id=2640013336","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640013336?lang=zh_cn&edition=full","pubTime":"2026-06-04 09:01","pubTimestamp":1780534885,"startTime":"0","endTime":"0","summary":"证券之星消息,迈克生物06月03日在投资者关系平台上答复投资者关心的问题。对医疗机构和患者都是非常有利的。智慧化实验室以患者为中心,打造基于自动化、数智化的医学实验室全面解决方案,构建“检验数据工厂+智能决策中心”两大核心价值单元。凭借完善的技术平台与丰富的产品矩阵,迈克搭建起智慧化实验室的核心建设基础,成功实现“智慧检验-智慧管理-智慧运营”的全流程闭环管理。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060400005066.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","BK0028","BK0012","300463"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640380871","title":"迈克生物:国内构建三级经销渠道","url":"https://stock-news.laohu8.com/highlight/detail?id=2640380871","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640380871?lang=zh_cn&edition=full","pubTime":"2026-06-04 08:51","pubTimestamp":1780534273,"startTime":"0","endTime":"0","summary":"证券之星消息,迈克生物06月03日在投资者关系平台上答复投资者关心的问题。投资者提问:公司目前在国内构建了三级经销渠道,国内经销商达到61家,产品覆盖7800家医疗机构,二级和三级医院覆盖率达到26%和58%,以上这些是全国性的覆盖率还是包括了海外业务;海外业务聚焦“12+1”重点国家和地区是否主要为欧美市场迈克生物回复:尊敬的投资,您好!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060400004946.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300463","BK0012","BK0028","BK0239","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640994392","title":"迈克生物:公司对该业务的中长期发展目标保持坚定信心","url":"https://stock-news.laohu8.com/highlight/detail?id=2640994392","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640994392?lang=zh_cn&edition=full","pubTime":"2026-06-02 20:51","pubTimestamp":1780404671,"startTime":"0","endTime":"0","summary":"证券之星消息,迈克生物06月01日在投资者关系平台上答复投资者关心的问题。目前,国内能够提供完整智慧化实验室解决方案的厂家极为有限,公司对该业务的中长期发展目标保持坚定信心。公司将按照业务整体发展目标努力推进全年目标达成,相关签单、交付等具体经营数据,请关注公司后续定期报告及官方合规披露内容。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060200044695.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0012","BK0028","BK0239","300463"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1782863640017,"stockEarnings":[{"period":"1week","weight":-0.0506},{"period":"1month","weight":-0.1259},{"period":"3month","weight":-0.2525},{"period":"6month","weight":-0.2618},{"period":"1year","weight":-0.3059},{"period":"ytd","weight":-0.2618}],"compareEarnings":[{"period":"1week","weight":-0.0029},{"period":"1month","weight":0.0063},{"period":"3month","weight":0.0369},{"period":"6month","weight":0.0316},{"period":"1year","weight":0.1887},{"period":"ytd","weight":0.0316}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"迈克生物股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"36044人(较上一季度增加12.11%)","perCapita":"13638股","listingDate":"2015-05-28","address":"四川省成都市郫都区高新区百川路16号","registeredCapital":"60466万元","survey":" 迈克生物股份有限公司的主营业务是体外诊断产品的研发、生产、销售和服务。公司的主要产品是免疫、生化、分子诊断提取、分子诊断荧光PCR、血常规产品、凝血产品、血型产品、血气产品、尿液产品。","listedPrice":27.96},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"迈克生物(300463)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供迈克生物(300463)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"迈克生物,300463,迈克生物股票,迈克生物股票老虎,迈克生物股票老虎国际,迈克生物行情,迈克生物股票行情,迈克生物股价,迈克生物股市,迈克生物股票价格,迈克生物股票交易,迈克生物股票购买,迈克生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"迈克生物(300463)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供迈克生物(300463)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}